When Ralda Nehme, a cell biologist and neuroscientist, first started her lab at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard in 2018, she realized a gap in the field. She was adept at growing stem cells in the lab, converting them into neurons, and using those cells to study the effects of genetic mutations linked to schizophrenia. But she soon realized that to truly capture the complexity of human disease, she would need to study a large number of cells from many people with or without the disease and with different genetic backgrounds. Read More
No comments:
Post a Comment